Impact of COVID-19 Pandemic on Colorectal Cancer Screening Program
Open Access
- 29 July 2020
- journal article
- research article
- Published by Elsevier BV in Clinical Colorectal Cancer
- Vol. 20 (1), e5-e11
- https://doi.org/10.1016/j.clcc.2020.07.006
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Colorectal Cancer Health Disparities and the Role of US Law and Health PolicyGastroenterology, 2016
- Race/Ethnicity and Primary Language: Health Beliefs about Colorectal Cancer Screening in a Diverse, Low-Income PopulationJournal of Health Care for the Poor and Underserved, 2015
- Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy)Gut, 2014
- Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) GuidelineEndoscopy, 2013
- Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million testsGut, 2011
- Quality Indicators for Colonoscopy and the Risk of Interval CancerThe New England Journal of Medicine, 2010
- Utilization of lower gastrointestinal endoscopy and fecal occult blood test in 11 European countries: evidence from the Survey of Health, Aging and Retirement in Europe (SHARE)Endoscopy, 2010
- Systematic review: distribution of advanced neoplasia according to polyp size at screening colonoscopyAlimentary Pharmacology & Therapeutics, 2009
- The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented researchGastrointestinal Endoscopy, 2009
- Fecal Occult Blood Test Screening for Colorectal CancerGastrointestinal Endoscopy Clinics of North America, 2002